000 00988 a2200277 4500
005 20250517024519.0
264 0 _c20160414
008 201604s 0 0 eng d
022 _a1873-7560
024 7 _a10.1016/j.eururo.2014.12.065
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBuchwald, Zachary S
245 0 0 _aWords of wisdom. Re: MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.
_h[electronic resource]
260 _bEuropean urology
_cMay 2015
300 _a975 p.
_bdigital
500 _aPublication Type: Journal Article; Comment
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aMale
650 0 4 _aUrinary Bladder Neoplasms
_xtherapy
700 1 _aEfstathiou, Jason A
773 0 _tEuropean urology
_gvol. 67
_gno. 5
_gp. 975
856 4 0 _uhttps://doi.org/10.1016/j.eururo.2014.12.065
_zAvailable from publisher's website
999 _c24777695
_d24777695